# Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

> **NCT00507221** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 948 (actual)

## Conditions studied

- HIV Infections
- Helminthiasis

## Interventions

- **DRUG:** Albendazole
- **DRUG:** Praziquantel
- **DRUG:** Current standard of care in Kenya

## Key facts

- **NCT ID:** NCT00507221
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-10
- **Target enrollment:** 948 (ACTUAL)
- **Last updated:** 2014-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507221, "Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00507221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*